Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn's disease

Research output: Contribution to journalReviewResearchpeer-review

  1. Systematic review with meta-analysis: encapsulated faecal microbiota transplantation - evidence for clinical efficacy

    Research output: Contribution to journalReviewResearchpeer-review

  2. Validation of claims-based indicators used to identify flare-ups in inflammatory bowel disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Pathophysiology and management of diabetic gastroenteropathy

    Research output: Contribution to journalReviewResearchpeer-review

  1. ECCO topical review: Refractory Inflammatory Bowel Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Progressive alcohol-related liver fibrosis is characterised by imbalanced collagen formation and degradation

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The burden of inflammatory bowel disease in Europe in 2020

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Background: Patients with Crohn’s disease (CD) are at increased risk of co-occurring immune-mediated inflammatory diseases (IMIDs). As discrepancy exists regarding the phenotypic presentation of CD among patients with such co-occurring IMIDs, we aimed to conduct a systematic review with meta-analysis characterizing the phenotype of CD among this subgroup of patients. Methods: PubMed, Embase, and Scopus were searched from their earliest records to October 2019 for studies reporting the behavior and localization of CD according to the Vienna or Montreal Classifications and CD-related surgery in patients with co-occurring IMIDs. These studies were the subject of a random effect meta-analysis. Results: After reviewing 24,413 studies, we identified a total of 23 studies comprising 1572 and 35,043 CD patients with and without co-occurring IMIDs, respectively, that fulfilled our inclusion criteria. Overall, patients with co-occurring IMIDs were more likely to have upper gastrointestinal inflammation than were patients without co-occurring IMIDs [relative risk (RR) = 1.49 (95% confidence interval (CI) 1.09–2.04), p = 0.01, I 2 = 7%]. In addition, presence of primary sclerosing cholangitis (PSC) was associated with a lower occurrence of ileal affection [RR = 0.44 (95% CI 0.24–0.81), p < 0.01, I 2 = 32%], increased occurrence of colonic affection [RR = 1.78 (95% CI 1.33–2.38), p < 0.01, I 2 = 32%] and an increased likelihood of non-stricturing and non-penetrating behavior [RR = 1.43 (95% CI 0.97–2.11), p = 0.07, I 2 = 86%]. The latter reached significance when cumulating different IMIDs [RR = 1.30 (95% CI 1.09–1.55), p < 0.01, I 2 = 88%]. CD patients with PSC also underwent fewer CD-related surgeries [RR = 0.55 (95% CI 0.34–0.88), p = 0.01, I 2 = 0%], irrespective of CD location or behavior. Conclusion: This study emphasizes that CD patients with co-existing PSC are likely to have a unique inflammatory distribution primarily confined to the colon, while patients with IMIDs in general have higher likelihood of affection of upper gastrointestinal tract and a non-stricturing and non-penetrating behavior. As such a phenotype of CD is typically associated with a milder disease course; future studies are needed to confirm these results.

Original languageEnglish
JournalTherapeutic Advances in Gastroenterology
Volume14
ISSN1756-283X
DOIs
Publication statusE-pub ahead of print - 22 Jun 2021

    Research areas

  • Crohn’s disease, disease behavior, disease localization, disease presentation, immune-mediated inflammatory diseases, primary sclerosing cholangitis

ID: 66571336